UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pericardium in Stable and Decompensated Heart Failure

Cardiology, 2024-06, Vol.149 (3), p.250-251

2024

Volltextzugriff (PDF)

Low-normal systolic function and hypertrophic cardiomyopathy

Heart (British Cardiac Society), 2023-05, Vol.109 (10), p.732-733

Rubis, Pawel

2023

Volltextzugriff (PDF)

Prognostic scales in dilated cardiomyopathy – Past, present, and future

International journal of cardiology, 2024-03, Vol.399, p.131655-131655, Article 131655

Rubis, Pawel

2024

Volltextzugriff (PDF)

High variability in assays of blood markers of collagen turnover in cardiovascular disease: Implications for research and clinical practice

European journal of heart failure, 2024-07

2024

Volltextzugriff (PDF)

Temporal progression of replacement and interstitial fibrosis in optimally managed dilated cardiomyopathy patients: A prospective study

International journal of cardiology, 2024-07, Vol.407, p.131988-131988, Article 131988

2024

Volltextzugriff (PDF)

Brugada syndrome: 2017 update. (RCD code: V-1A.1)

Journal of rare cardiovascular diseases, 2017-09, Vol.3 (4), p.108

Rubis, Pawel

2017

Volltextzugriff (PDF)

Mortality risk assessment in dilated cardiomyopathy: the Krakow DCM Risk Score

Kardiologia polska, 2021-02, Vol.79 (2), p.215-216

2021

Volltextzugriff (PDF)

Beyond the classic risk factors in atherosclerosis – the promise of metabolomics and other -omics in life-style acquired cardiovascular diseases

International journal of cardiology, 2021-09, Vol.339, p.167-169

Rubis, Pawel

2021

Volltextzugriff (PDF)

To what extent does prior antimicrobial therapy affect the diagnostic performance of radiolabeled leukocyte scintigraphy in infective endocarditis?

Journal of nuclear cardiology, 2023-02, Vol.30 (1), p.343-353

2023

Volltextzugriff (PDF)

Identification and therapy for patients with heart failure with preserved ejection fraction: An expert opinion of the Heart Failure Association of the Polish Cardiac Society

Kardiologia polska (1957), 2024-01, Vol.82 (2), p.247-254

2024

Volltextzugriff (PDF)

The Diagnostic Value of 99mTc-HMPAO-Labelled White Blood Cell Scintigraphy and 18F-FDG PET/CT in Cardiac Device-Related Infective Endocarditis—A Systematic Review

Journal of personalized medicine, 2021-10, Vol.11 (10), p.1016

2021

Volltextzugriff (PDF)

Improved survival of left ventricular assist device carriers in Europe according to implantation eras: results from the PCHF‐VAD registry

European journal of heart failure, 2022-07, Vol.24 (7), p.1305-1315

2022

Volltextzugriff (PDF)

Hypertrophic cardiomyopathy and left ventricular non-compaction: Distinct diseases or variant phenotypes of a single condition?

World journal of cardiology, 2024-09, Vol.16 (9), p.496-501

2024

Volltextzugriff (PDF)

Multimodality family screening of patients with cardiac transthyretin amyloidosis: a case of an asymptomatic patient

European heart journal : case reports, 2023-05, Vol.7 (5), p.ytad200

2023

Volltextzugriff (PDF)

Mitral regurgitation severity dynamic during acute decompensated heart failure treatment

The international journal of cardiovascular imaging, 2022-05, Vol.38 (5), p.1113-1119

2022

Volltextzugriff (PDF)

Sacubitril/valsartan for heart failure with reduced ejection fraction: A first real-life observational study in Poland

Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2021-01, Vol.30 (1), p.67

2021

Volltextzugriff (PDF)

12-month patterns of serum markers of collagen synthesis, transforming growth factor and connective tissue growth factor are similar in new-onset and chronic dilated cardiomyopathy in patients both with and without cardiac fibrosis

Cytokine (Philadelphia, Pa.), 2017-08, Vol.96, p.217-227

2017

Volltextzugriff (PDF)

Comparison of the 12-month kinetics of the serum markers of fibrosis between treatment with angiotensin receptor-neprilysin inhibitors and angiotensin-converting enzyme inhibitors in patients with heart failure with reduced ejection fraction

Polskie archiwum medycyny wewne̦trznej, 2020-11, Vol.130 (11), p.1017-1020

2020

Volltextzugriff (PDF)

From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis

Polskie archiwum medycyny wewne̦trznej, 2020-02, Vol.130 (2), p.153-154

2020

Volltextzugriff (PDF)

Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR

Heart and vessels, 2017-06, Vol.32 (6), p.714-725

2017

Volltextzugriff (PDF)

Extracellular volume is an independent predictor of arrhythmic burden in dilated cardiomyopathy

Scientific reports, 2021-12, Vol.11 (1), p.24000-10, Article 24000

2021

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(138)

Publikationsform

Artikel
(157)
Berichte
(1)

Sprache

Englisch
(154)
Polnisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Pericardium in Stable and Decompensated Heart Failure

Low-normal systolic function and hypertrophic cardiomyopathy

Prognostic scales in dilated cardiomyopathy – Past, present, and future

High variability in assays of blood markers of collagen turnover in cardiovascular disease: Implications for research and clinical practice

Temporal progression of replacement and interstitial fibrosis in optimally managed dilated cardiomyopathy patients: A prospective study

Brugada syndrome: 2017 update. (RCD code: V-1A.1)

Mortality risk assessment in dilated cardiomyopathy: the Krakow DCM Risk Score

Beyond the classic risk factors in atherosclerosis – the promise of metabolomics and other -omics in life-style acquired cardiovascular diseases

To what extent does prior antimicrobial therapy affect the diagnostic performance of radiolabeled leukocyte scintigraphy in infective endocarditis?

Impact of progressive aortic regurgitation on outcomes after left ventricular assist device implantation

Identification and therapy for patients with heart failure with preserved ejection fraction: An expert opinion of the Heart Failure Association of the Polish Cardiac Society

The Diagnostic Value of 99mTc-HMPAO-Labelled White Blood Cell Scintigraphy and 18F-FDG PET/CT in Cardiac Device-Related Infective Endocarditis—A Systematic Review

Improved survival of left ventricular assist device carriers in Europe according to implantation eras: results from the PCHF‐VAD registry

Hypertrophic cardiomyopathy and left ventricular non-compaction: Distinct diseases or variant phenotypes of a single condition?

Multimodality family screening of patients with cardiac transthyretin amyloidosis: a case of an asymptomatic patient

Mitral regurgitation severity dynamic during acute decompensated heart failure treatment

Sacubitril/valsartan for heart failure with reduced ejection fraction: A first real-life observational study in Poland

12-month patterns of serum markers of collagen synthesis, transforming growth factor and connective tissue growth factor are similar in new-onset and chronic dilated cardiomyopathy in patients both with and without cardiac fibrosis

Comparison of the 12-month kinetics of the serum markers of fibrosis between treatment with angiotensin receptor-neprilysin inhibitors and angiotensin-converting enzyme inhibitors in patients with heart failure with reduced ejection fraction

From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis

Genetic testing for inherited cardiovascular diseases. A position statement of the Polish Cardiac Society endorsed by Polish Society of Human Genetics and Cardiovascular Patient Communities

How does age affect outcomes after left ventricular assist device implantation: results from the PCHF‐VAD registry

Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR

Extracellular volume is an independent predictor of arrhythmic burden in dilated cardiomyopathy

Sex‐related differences in left ventricular assist device utilization and outcomes: results from the PCHF‐VAD registry

Suchergebnisse filtern